Hosted on MSN14h
Chocolate Recall Considered Class I Due to 'Deadly' Allergen Risk, FDA Warns
The chocolate snacks were distributed to nine states. In December, the United States Food and Drug Administration (FDA) ...
RenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery ...